These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31671722)

  • 21. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
    Chen RZ; Akbarian S; Tudor M; Jaenisch R
    Nat Genet; 2001 Mar; 27(3):327-31. PubMed ID: 11242118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems.
    Kudo S; Nomura Y; Segawa M; Fujita N; Nakao M; Dragich J; Schanen C; Tamura M
    Brain Dev; 2001 Dec; 23 Suppl 1():S165-73. PubMed ID: 11738866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders.
    Baker SA; Chen L; Wilkins AD; Yu P; Lichtarge O; Zoghbi HY
    Cell; 2013 Feb; 152(5):984-96. PubMed ID: 23452848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stalled replication forks within heterochromatin require ATRX for protection.
    Huh MS; Ivanochko D; Hashem LE; Curtin M; Delorme M; Goodall E; Yan K; Picketts DJ
    Cell Death Dis; 2016 May; 7(5):e2220. PubMed ID: 27171262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation.
    Cheung AY; Horvath LM; Grafodatskaya D; Pasceri P; Weksberg R; Hotta A; Carrel L; Ellis J
    Hum Mol Genet; 2011 Jun; 20(11):2103-15. PubMed ID: 21372149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients.
    Ballestar E; Ropero S; Alaminos M; Armstrong J; Setien F; Agrelo R; Fraga MF; Herranz M; Avila S; Pineda M; Monros E; Esteller M
    Hum Genet; 2005 Jan; 116(1-2):91-104. PubMed ID: 15549394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain.
    Kudo S; Nomura Y; Segawa M; Fujita N; Nakao M; Schanen C; Tamura M
    J Med Genet; 2003 Jul; 40(7):487-93. PubMed ID: 12843318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.
    Okabe Y; Kusaga A; Takahashi T; Mitsumasu C; Murai Y; Tanaka E; Higashi H; Matsuishi T; Kosai K
    Brain Res; 2010 Nov; 1360():17-27. PubMed ID: 20816763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.
    Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
    Brain Dev; 2012 Jun; 34(6):487-95. PubMed ID: 21982064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MeCP2 interacts with HP1 and modulates its heterochromatin association during myogenic differentiation.
    Agarwal N; Hardt T; Brero A; Nowak D; Rothbauer U; Becker A; Leonhardt H; Cardoso MC
    Nucleic Acids Res; 2007; 35(16):5402-8. PubMed ID: 17698499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular pathology of Rett syndrome: synopsis and update.
    Akbarian S; Jiang Y; Laforet G
    Neuromolecular Med; 2006; 8(4):485-94. PubMed ID: 17028371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
    Braunschweig D; Simcox T; Samaco RC; LaSalle JM
    Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice.
    Heckman LD; Chahrour MH; Zoghbi HY
    Elife; 2014 Jun; 3():. PubMed ID: 24970834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome.
    Martínez de Paz A; Ausió J
    Adv Exp Med Biol; 2017; 978():3-21. PubMed ID: 28523538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MeCP2 Levels Regulate the 3D Structure of Heterochromatic Foci in Mouse Neurons.
    Ito-Ishida A; Baker SA; Sillitoe RV; Sun Y; Zhou J; Ono Y; Iwakiri J; Yuzaki M; Zoghbi HY
    J Neurosci; 2020 Nov; 40(45):8746-8766. PubMed ID: 33046553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2.
    Chen X; Han X; Blanchi B; Guan W; Ge W; Yu YC; Sun YE
    Protein Cell; 2021 Aug; 12(8):639-652. PubMed ID: 32851591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MECP2 disorders: from the clinic to mice and back.
    Lombardi LM; Baker SA; Zoghbi HY
    J Clin Invest; 2015 Aug; 125(8):2914-23. PubMed ID: 26237041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein complex of Drosophila ATRX/XNP and HP1a is required for the formation of pericentric beta-heterochromatin in vivo.
    Emelyanov AV; Konev AY; Vershilova E; Fyodorov DV
    J Biol Chem; 2010 May; 285(20):15027-15037. PubMed ID: 20154359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
    Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ATRX in chromatin assembly and genome architecture during development and disease.
    Bérubé NG
    Biochem Cell Biol; 2011 Oct; 89(5):435-44. PubMed ID: 21851155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.